{"id":35546,"date":"2026-04-08T07:35:41","date_gmt":"2026-04-08T05:35:41","guid":{"rendered":"https:\/\/www.gauteng.net\/whats-on-g\/?p=35546"},"modified":"2026-04-08T07:35:42","modified_gmt":"2026-04-08T05:35:42","slug":"first-lenacapavir-hiv-prevention","status":"publish","type":"post","link":"https:\/\/www.gauteng.net\/whats-on-g\/first-lenacapavir-hiv-prevention\/","title":{"rendered":"South Africa Gets First Lenacapavir HIV Prevention Injection in Major Health Shift"},"content":{"rendered":"\n<p>South Africa has received its first batch of the long-acting HIV prevention injection Lenacapavir, with 37 920 doses now in the country. The Department of Health confirmed the development this week, signalling a shift in how HIV prevention could be delivered, particularly in high-burden provinces like Gauteng. The rollout matters now as health officials look to improve adherence and reduce new infections using alternatives to daily medication.<\/p>\n\n\n\n<p>The six-monthly injectable is expected to form part of South Africa\u2019s broader HIV prevention strategy, with a national rollout plan set to be announced in the coming weeks.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.gauteng.net\/whats-on-g\/gauteng-load-reduction-schedule-2\/\"><strong>ALSO READ: Gauteng Load Reduction Schedule for 7 to 13 April 2026: Full Timetable and Affected Areas<\/strong><\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">South Africa Introduces Long-acting HIV Prevention Injection<\/h2>\n\n\n\n<p>The Department of Health said Lenacapavir will be integrated into its existing HIV prevention programmes as part of a people-centred approach aligned with the Global AIDS Strategy for 2026 to 2030.<\/p>\n\n\n\n<p>According to spokesperson Foster Mohale, the injection is designed to expand prevention options and reach individuals who face barriers to current HIV prevention methods.<\/p>\n\n\n\n<p>\u201cThis is part of integrated, differentiated and people-centred HIV prevention services which offer new hope for people who face barriers to existing HIV prevention methods,\u201d Mohale said.<\/p>\n\n\n\n<p>The department emphasised that the injectable will complement, rather than replace, existing prevention tools.<\/p>\n\n\n\n<div id=\"gaute-813164598\" class=\"gaute-inbetween-content\" style=\"margin-top: 30px;margin-bottom: 30px;margin-left: auto;margin-right: auto;text-align: center;\"><div class=\"gaute-adlabel\">Advertisement<\/div><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-1852772760112594\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-1852772760112594\" \ndata-ad-slot=\"1819787043\" \ndata-ad-format=\"auto\" data-full-width-responsive=\"true\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div><h2 class=\"wp-block-heading\">Six-monthly Dosing Expected to Improve Adherence<\/h2>\n\n\n\n<p><a href=\"https:\/\/www.who.int\/news\/item\/14-07-2025-who-recommends-injectable-lenacapavir-for-hiv-prevention\" target=\"_blank\" rel=\"noopener\">Lenacapavir<\/a> is administered as a subcutaneous injection twice a year, significantly reducing the need for daily oral prevention medication.<\/p>\n\n\n\n<p>Health officials say this feature could improve adherence among groups that struggle to maintain daily treatment routines.<\/p>\n\n\n\n<p>Priority groups identified include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Adolescent girls and young women<\/li>\n\n\n\n<li>Sex workers<\/li>\n\n\n\n<li>Men who have sex with men<\/li>\n\n\n\n<li>Individuals at high risk of HIV exposure<\/li>\n<\/ul>\n\n\n\n<p>According to the department, improving adherence is central to reducing infection rates, particularly in densely populated provinces such as Gauteng.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Rollout Details to be Announced by Health Minister<\/h2>\n\n\n\n<p><a href=\"https:\/\/www.health.gov.za\/\" target=\"_blank\" rel=\"noopener\">The Department of Health<\/a> said a phased rollout plan will be confirmed soon, with an official launch expected to be led by Health Minister Dr Aaron Motsoaledi.<\/p>\n\n\n\n<p>While details are still pending, officials indicated that:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>High-risk populations will be prioritised<\/li>\n\n\n\n<li>Rollout will be phased across provinces<\/li>\n\n\n\n<li>Public healthcare facilities will play a central role<\/li>\n<\/ul>\n\n\n\n<p>The department has not yet confirmed timelines or specific distribution sites.<\/p>\n\n\n\n<div id=\"gaute-2781307657\" class=\"gaute-inbetween-content\" style=\"margin-top: 30px;margin-bottom: 30px;margin-left: auto;margin-right: auto;text-align: center;\"><div class=\"gaute-adlabel\">Advertisement<\/div><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-1852772760112594\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-1852772760112594\" \ndata-ad-slot=\"1819787043\" \ndata-ad-format=\"auto\" data-full-width-responsive=\"true\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div><h2 class=\"wp-block-heading\">SAHPRA Approval Places South Africa at the Forefront of HIV Prevention<\/h2>\n\n\n\n<p>Lenacapavir was registered by the <a href=\"https:\/\/www.sahpra.org.za\/\" target=\"_blank\" rel=\"noopener\">South African Health Products Regulatory Authority<\/a> in October 2025 under the brand name Sunlenca.<\/p>\n\n\n\n<p>This made South Africa the first country in Africa to approve the long-acting injectable for HIV prevention.<\/p>\n\n\n\n<p>Health experts say this positions the country at the forefront of adopting new prevention technologies, particularly as global efforts intensify to end AIDS as a public health threat by 2030.<\/p>\n\n\n\n<p>Clinical trial data has shown high levels of effectiveness, with significant reductions in new infections among participants.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why Lenacapavir is Considered a Major HIV Prevention Breakthrough<\/h2>\n\n\n\n<p>Health officials describe Lenacapavir as a potential \u201cgame changer\u201d due to its long-acting nature and simplified dosing schedule.<\/p>\n\n\n\n<p>Key advantages include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Reduced reliance on daily medication<\/li>\n\n\n\n<li>Improved adherence rates<\/li>\n\n\n\n<li>Lower risk of missed doses<\/li>\n\n\n\n<li>Expanded access for hard-to-reach populations<\/li>\n<\/ul>\n\n\n\n<p>Mohale said the injectable represents one of the most significant advances in HIV prevention in recent years.<\/p>\n\n\n\n<p>However, experts note that the success of the programme will depend on effective rollout and equitable access across provinces.<\/p>\n\n\n\n<div id=\"gaute-725928724\" class=\"gaute-inbetween-content\" style=\"margin-top: 30px;margin-bottom: 30px;margin-left: auto;margin-right: auto;text-align: center;\"><div class=\"gaute-adlabel\">Advertisement<\/div><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-1852772760112594\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-1852772760112594\" \ndata-ad-slot=\"1819787043\" \ndata-ad-format=\"auto\" data-full-width-responsive=\"true\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div><h2 class=\"wp-block-heading\">What This Means for Gauteng Residents<\/h2>\n\n\n\n<p>For Gauteng residents, the introduction of Lenacapavir could change how HIV prevention services are accessed.<\/p>\n\n\n\n<p>The province continues to carry a high HIV burden, particularly among young people and urban communities.<\/p>\n\n\n\n<p>The new injection means:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fewer clinic visits compared to daily medication<\/li>\n\n\n\n<li>Greater flexibility in prevention options<\/li>\n\n\n\n<li>Potential improvement in long-term adherence<\/li>\n\n\n\n<li>Expanded access for vulnerable groups<\/li>\n<\/ul>\n\n\n\n<p>However, access will depend on how quickly the rollout is implemented within Gauteng\u2019s healthcare system.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">FAQ: Lenacapavir HIV prevention injection<\/h2>\n\n\n\n<p><strong>What is Lenacapavir?<\/strong><br>It is a long-acting injectable used for HIV prevention and treatment, administered twice a year.<\/p>\n\n\n\n<p><strong>Is Lenacapavir a vaccine?<\/strong><br>No. It is a preventive medication, not a vaccine.<\/p>\n\n\n\n<p><strong>Who will receive it first?<\/strong><br>High-risk groups will be prioritised during the initial rollout phase.<\/p>\n\n\n\n<p><strong>When will it be available?<\/strong><br>The Department of Health has not yet confirmed an official rollout date.<\/p>\n\n\n\n<p><strong>Why is it important?<\/strong><br>It offers an alternative to daily HIV prevention pills, which may improve adherence and reduce new infections.<\/p>\n\n\n\n<div id=\"gaute-1750839981\" class=\"gaute-inbetween-content\" style=\"margin-top: 30px;margin-bottom: 30px;margin-left: auto;margin-right: auto;text-align: center;\"><div class=\"gaute-adlabel\">Advertisement<\/div><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-1852772760112594\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-1852772760112594\" \ndata-ad-slot=\"1819787043\" \ndata-ad-format=\"auto\" data-full-width-responsive=\"true\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div><h2 class=\"wp-block-heading\">What Happens Next<\/h2>\n\n\n\n<p>The Department of Health is expected to release further details on rollout timelines and distribution plans in the coming weeks.<\/p>\n\n\n\n<p>Health authorities will also monitor early uptake and outcomes as the programme is introduced across provinces.<\/p>\n\n\n\n<p>The success of Lenacapavir in South Africa may influence future HIV prevention strategies as the country works toward its 2030 targets.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>South Africa has received its first batch of the long-acting HIV prevention injection Lenacapavir, with 37 920 doses now in the country. The Department of Health confirmed the development this week, signalling a shift in how HIV prevention could be delivered, particularly in high-burden provinces like Gauteng. The rollout matters now as health officials look to improve adherence and reduce new infections using alternatives to daily medication.<\/p>\n","protected":false},"author":23,"featured_media":35551,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"rank_math_focus_keyword":"","rank_math_title":"","rank_math_description":"","footnotes":""},"categories":[47],"tags":[11481,11480,2220],"class_list":{"0":"post-35546","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-news","8":"tag-hiv-aids","9":"tag-public-announcement","10":"tag-south-africa-news"},"_links":{"self":[{"href":"https:\/\/www.gauteng.net\/whats-on-g\/wp-json\/wp\/v2\/posts\/35546","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gauteng.net\/whats-on-g\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gauteng.net\/whats-on-g\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gauteng.net\/whats-on-g\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gauteng.net\/whats-on-g\/wp-json\/wp\/v2\/comments?post=35546"}],"version-history":[{"count":4,"href":"https:\/\/www.gauteng.net\/whats-on-g\/wp-json\/wp\/v2\/posts\/35546\/revisions"}],"predecessor-version":[{"id":35550,"href":"https:\/\/www.gauteng.net\/whats-on-g\/wp-json\/wp\/v2\/posts\/35546\/revisions\/35550"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.gauteng.net\/whats-on-g\/wp-json\/wp\/v2\/media\/35551"}],"wp:attachment":[{"href":"https:\/\/www.gauteng.net\/whats-on-g\/wp-json\/wp\/v2\/media?parent=35546"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gauteng.net\/whats-on-g\/wp-json\/wp\/v2\/categories?post=35546"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gauteng.net\/whats-on-g\/wp-json\/wp\/v2\/tags?post=35546"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}